Search

Publications

Ruxolitinib for the management of myelofibrosis: Results of an international physician survey. Ellis MH, Koren-Michowitz M, Lavi N, Vannucchi AM, Mesa R, Harrison CN. Leuk Res. 2017 Oct;61:6-9. doi: 10. 1016/j. leukres. 2017. 08. 002.

Read more

Publications

For the subgroup Rare hereditary blood cancers:
GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML.

Read more

SWG Educational Activities

The SWG's recent educational activities have included:

Meetings with the SWG on Myelodysplastic Syndromes and the SWG on Acute Myeloid Leukemia
An EHA-SWG Scientific Meeting on 'MDS/MPN/AML: Commonalities and Differences of Myeloid Neoplasms'
An oral presentation for the American Society of Hematology (ASH)…

Read more

Presentations

EHA-MSH Hematology Tutorial 

Session 1: Basic Principles of Hodgkin Lymphoma

Lecture: MJ Kersten (Not available)
Clinical Case: PL Low (Not available)
Self-assessment case: MJ Kersten (Not available)
Session 2: Histopathology and Diagnosis

Lecture: MA Piris (here)
Clinical Case: CC Liong (here)
Self-assessment case: MA Piris (here)
Session 3: Treatment of Newly Diagnosed Hodgkin Lymphoma

Lecture: A Czyż (here)
Clinical…

Read more

EHA Blood Cancer Awareness Month Wrap-up

The first European Hematology Association (EHA) Blood Cancer Awareness Month digital campaign aimed to raise awareness of hematological malignancies and EHA’s commitment “towards a cure for all blood disorders”.

Read more

Report Drug Shortages to EHA

In an effort to mitigate shortages of hematologic drugs in Europe, EHA is collecting and compiling reports of shortages. Are you experiencing, or foreseeing drug shortages in your clinical practice?

Please report those to drugshortage@ehaweb. org.

Read more